Abstract: Nitrile hydratase (NHase), an industrially important enzyme that catalyzes the hydration of nitriles to their corresponding amides, has only been characterized from prokaryotic microbes. The putative NHase from the eukaryotic unicellular choanoflagellate organism Monosiga brevicollis (MbNHase) was heterologously expressed in Escherichia coli. The resulting enzyme expressed as a single polypeptide with fused α-and β-subunits linked by a seventeen-histidine region. Size-exclusion chromatography indicated that MbNHase exists primarily as an (αβ)2 homodimer in solution, analogous to the α2β2 homotetramer architecture observed for prokaryotic NHases. The NHase enzyme contained its full complement of Co(III) and was fully functional without the co-expression of an activator protein or E. coli GroES/EL molecular chaperones. The homology model of MbNHase was developed identifying Cys400, Cys403, and Cys405 as active site ligands. The results presented here provide the first experimental data for a mature and active eukaryotic NHase with fused subunits. Since this new member of the NHase family is expressed from a single gene without the requirement of an activator protein, it represents an alternative biocatalyst for industrial syntheses of important amide compounds. Abbreviations  NHase, nitrile hydratase;
Introduction
Nitrile hydratases (NHases, EC 4.2.1.84) catalyze the hydration of nitriles to their corresponding amides. 1, 2 Since the currently employed industrial conditions used to hydrate nitriles to amides (either acid or base hydration), are often incompatible with the sensitive structures of many industrially and synthetically relevant compounds, NHases have attracted substantial interest as biocatalysts in preparative organic chemistry. For example, acrylonitrile and adiponitrile are used in the production of polyacrylamide and nylon-66, respectively, the latter of which is one of the most important industrial polyamides. 3 Nitriles are also often used as synthetic starting materials since they add an extra carbon atom to an alkyl chain. Since nitriles are synthesized by plants, fungi, bacteria, algae, insects and sponges, there are several biochemical pathways for nitrile degradation. 4 Enzymes involved in nitrile degradation pathways represent chemoselective biocatalysts capable of hydrating nitriles under physiological reaction conditions. 4, 5 Fig. 1. Alignment of the amino acid sequence of the eukaryotic NHase from M. brevicollis and prokaryotic nitrile hydratases. A) Amino acid alignment of the N-terminus residues of the eukaryotic NHase from M. brevicollis and prokaryotic NHase β-subunits. B) Amino acid alignment of the C-terminus residues of the eukaryotic NHase from M. brevicollis and prokaryotic NHase α-subunits. Conserved residues among MbNHase and prokaryotic NHases are highlighted in black and gray. The metal-binding motif is highlighted in cyan and active site Co-type NHase residues are in orange. The histidine-rich region is highlighted in light yellow. MbNHase from M. brevicollis; Co-NHases: PtNHase (Pseudonocardia thermophila JCM 3095), Rh_LM, (low-molecular weight, Rhodococcus rhodochrous J1), Rh_HM (high-molecular weight, Rhodococcus rhodochrous J1); Iron-NHases: Rh_N-771 (Rhodococcus sp. N-771), Ct (Comamonas testosteroni Ni1), Re (Rhodococcus equi TG328-2); SCN_alpha, SCN_beta, and SCN_gamma, cobalt thiocyanate hydrolase (SCNase) from Thiobacillus thioparus THI115.
As no eukaryotic NHase enzyme has yet been described, we set out to determine whether the putative NHase gene from M. brevicollis does indeed code for a functional NHase. The gene encoding the fused α-and β-subunits of the hypothetical NHase from M. brevicollis was heterologously expressed in E. coli. The resulting enzyme contained its full complement of Co(III) and was a fully functional NHase, all without the co-expression of an activator protein or E. coli GroES/EL molecular chaperones. This is the first report of a eukaryotic NHase and because this new member of the NHase family is expressed from a single gene without the requirement of an activator protein, it represents an alternative biocatalyst for industrial syntheses of important amide compounds.
Materials and methods

Materials
Acrylonitrile, Tris-HCl, and HEPES were obtained from SigmaAldrich (St. Louis, MO, USA). All other materials were purchased at the highest quality available.
Plasmid construction
Protein sequences for the α-and β-subunit genes of the putative MbNHase were obtained from ORF 37534 (UniProt ID A9V2C1.1) of M. brevicollis. The predicted gene was synthesized by Integrated DNA Technologies, Inc. with optimized E. coli codon usage (SI Fig. 1 ) and cloned into the pIDT-SMART kanamycin resistant vector with NdeI and HindIII restriction sites. The gene was subsequently digested and ligated into the ampicillin resistant pET21a + (EMD Biosciences) expression vector to create the plasmid pSMMαβ. The sequence was confirmed using automated DNA sequencing at the University of Chicago Cancer Research Center DNA sequencing facility.
Expression of recombinant MbNHase in the absence of an activator protein
The hypothetical MbNHase gene was expressed alone, without co-expressing a Co-type activator protein or the E. coli chaperones GroES/EL, in the following manner. The pSMMαβ plasmid was freshly transformed into E. coli BL21(DE3) competent cells (Agilent accessed by following the link in the citation at the bottom of the page.
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Technologies) and a single colony was used to inoculate a 50 mL LBMiller culture containing 50 μg/mL of carbenicillin with shaking overnight at 37 °C. This culture (~ 7 mL) was used to inoculate a 1 L culture containing 100 μg/mL of ampicillin and the cells were grown at 37 °C until the OD600 nm reached 0.8-1.0. The culture was cooled on ice to 20 °C, induced with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) in the presence of 0.25 mM CoCl2 and expressed at 20 °C for 16 h. Cells were harvested by centrifugation at 6370 × g for 10 min at 4 °C in a Beckman Coulter Avanti JA-10 rotor. Cell pellets were resuspended in buffer A (50 mM NaH2PO4 pH 8.0, 500 mM NaCl, and 10 mM imidazole with 5% glycerol) at a ratio of 5 mL per gram of cells, then sonicated for 4 min (30 s on 45 s off) at 21 W using a Misonix sonicator 3000. The crude extract was obtained after centrifugation in a JA-20 rotor at 31,000 × g and 4 °C for 20 min. The sample was subjected to another round of centrifugation before purification to remove particulate matter.
Purification of recombinant MbNHase
Crude extracts of MbNHase were loaded onto a 5 mL Ni(II)-nitrilotriacetic acid (NTA) Superflow Cartridge (Qiagen) for immobilized metal affinity chromatography (IMAC) using an ÄKTA FPLC P-960 column. The column was washed with four column volumes (CVs) of buffer A (50 mM NaH2PO4 pH 8.0, 500 mM NaCl, and 35 mM imidazole) followed by washes with 50 mM HEPES pH 8.0, 500 mM NaCl containing 60 mM and 110 mM imidazole, respectively. The protein was eluted with a linear gradient (0-100%) of buffer B (50 mM HEPES pH 8.0, 500 mM NaCl with 500 mM imidazole) over 20 CVs at a flow rate of 1 mL/min. Active protein fractions were pooled and concentrated with an Amicon Ultra-15 10,000 MWCO centrifugal filter unit (Millipore) resulting in ~ 10 mg/L of culture containing soluble MbNHase. Size-exclusion chromatography was used to remove remaining impurities and to assess the quaternary structure of MbNHase ( Fig. SI-2) . A 16/60 Superdex 200 prep grade (GE Healthcare) column was calibrated from 12.4 to 200 kDa using the MWGF200 gel filtration calibration kit (Sigma). Purified protein samples were analyzed by SDS-PAGE with a 12.5% polyacrylamide SPRINT NEXT GEL™ (Amresco). Gels were stained with Gel Code Blue (Thermo-Fisher Scientific). Protein concentration of purified protein accessed by following the link in the citation at the bottom of the page.
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was determined using either a Coomassie (Bradford) Protein Assay Kit (Pierce) or by measuring the absorbance at 280 nm on a Shimadzu UV-2450 spectrophotometer. Theoretical molecular weights and protein extinction coefficients were calculated with the ExPASy compute pI/Mw tool. 16 The molecular weight for the MbNHase homodimer was 111,207 g/mol with an extinction coefficient of 143,700 cm
The molecular weight is in good agreement with SDS-PAGE data.
Kinetic analysis of MbNHase
The enzymatic activity of MbNHase towards acrylonitrile (acrylamide; Δε225 = 2.9 mM − 1 cm − 1 ) and benzonitrile (benzamide; Δε242 = 5.5 mM − 1 cm − 1 ), was measured using a Shimadzu UV-2450 spectrophotometer. A 1 mL reaction consisted of 50 mM Tris-HCl buffer pH 7.0 at 25 °C and various concentrations of acrylonitrile or benzonitrile.
17 Data analysis was performed using OriginPro 9.0 (OriginLab, Northampton, MA). The kinetic constants Vmax and Km (were calculated by fitting the data to the Michaelis and Menten equation. One unit of enzyme activity was defined as the amount of enzyme that catalyzed the production of 1 μmol of the amide per minute at 25 °C.
Metal analysis
The metal content of purified protein was determined by inductively-coupled plasma mass spectrometry (ICP-MS). Purified MbNHase (1 mg) expressed in the presence and absence of added CoCl2. For comparison purposes, the Co-type NHase from Pseudonocardia thermophila JCM 3095 (PtNHase) (1 mg) was expressed and purified as previously described, 18 and examined along with a control of buffer containing no protein. All protein samples were digested with concentrated nitric acid (0.863 mL) and heated at 70 °C for 1 h, allowed to cool to room temperature and then diluted to final concentration of 5% nitric acid. Samples were submitted for analysis at the Water Quality Center in the College of Engineering at Marquette University (Milwaukee, WI, USA).
Electronic absorption spectra
Electronic absorption spectra were recorded on a Shimadzu UV-2600 spectrophotometer equipped with a TCC-240A temperature controlled cell holder. Spectra of MbNHase and PtNHase were obtained at 25 °C in a 1 cm quartz cuvette in 50 mM HEPES buffer containing 300 mM NaCl, pH 8.0, for MbNHase or pH 7.5 for PtNHase.
Homology model of the MbNHase
A homology model of the MbNHase was developed using the Xray crystal structure of PtNHase (PDB code:1IRE) as a template. 19, 20 Sequence analysis of the target and template α-and β-subunits only, revealed that these proteins are of similar length, with a sequence identity of 29%, and exhibit no significant sequence gaps. The YASARA homology-building program was used to construct the structural homology model of MbNHase. 21, 22 Comparison of the energy minimized MbNHase α-and β-subunit homology model to the X-ray crystal structure of PtNHase, using the MatchMaker in UCSF Chimera, reveals that the MbNHase α-and β-subunit homology model displays the typical dimerization and catalytic domains of PtNHase with a Needleman-Wunsch 23 score of 285 and an average RMSD of 1.129 Å over the aligned 354 Cα atom pairs.
Results and discussion
Sequence alignment of MbNHase with prokaryotic NHases
The predicted NHase polypeptide encoded by the M. brevicollis ORF 37534 contains 495 amino acids.
14 The first ~ 240 AA of the Nterminus of this putative NHase align with the β-subunit of prokaryotic NHases (Fig. 1A) , while the last ~ 240 AA of the C-terminus aligns with, and has high similarity (35-45%) with prokaryotic NHase α-subunits (Fig. 1A) . The α-and β-subunit regions in MbNHase are connected by a histidine rich region containing seventeen histidine residues while the C-terminus region contains the signature NHase metal-binding domain of Co-type NHases (Fig. 1B) . accessed by following the link in the citation at the bottom of the page. 
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Characteristics of purified MbNHase
MbNHase was expressed in E. coli without the co-expression of the E. coli molecular chaperones GroES/EL or an activator protein. The protein was purified by IMAC using the seventeen His residues naturally encoded in the insert between the α-and β-subunit regions as the tag, providing ~ 10 mg/L of soluble protein. SDS-PAGE analysis revealed a band with molecular weight of ~ 55 kDa ( Fig. 2A) , which is in good agreement with the theoretical molecular weight of 55.6 kDa. A faint second band is also observed at ~ 110 kDa, which is consistent with a small fraction of MbNHase homodimer (111.2 kDa) that was not fully denatured under the conditions used. In contrast to prokaryotic NHases, MbNHase is expressed as a fused protein where both the α-and β-subunits reside in a single polypeptide as predicted by Foerstner et al.
14 Even though this is the first example of a fused eukaryotic NHase, the expression of a subunit-fused bacterial NHase from Pseudomonas putida 24 has also been reported, however, in this case the subunit-fusion was accomplished by engineering a proline-glycine dipeptide linker between the two subunit genes by PCR. Size-exclusion chromatography indicated that MbNHase exists primarily as an (αβ)2 homodimer in solution, analogous to the α2β2 homotetramer architecture observed for prokaryotic NHases, with a small fraction (< 10%) present as a monomer ( Fig. SI-2 ).
Kinetic characterization of MbNHase
Kinetic analysis revealed that MbNHase expressed in the presence of 0.25 mM CoCl2 is capable of hydrating acrylonitrile, the standard substrate for NHase kinetic analysis, with a kcat of 130 ± 3 s − 1 and a Km of 78 ± 3 mM, providing a catalytic efficiency kcat/Km of 1.7 s
Since the turnover rate is in line with other reported Co-type NHase enzymes (kcat = 50 to 1500 s − 1 ), 2, 18 it was hypothesized that the metal ion was properly inserted and that both active site Cys residues (Cys403 and Cys405) were properly oxidized in the absence of an activator protein, which is typically required for full NHase enzymatic activity. 7, 8, 9 MbNHase is also capable of hydrating benzonitrile with kcat of 33 ± 1 s − 1 and a Km = 18 ± 1 mM, providing a catalytic efficiency kcat/Km of 1.8 s − 1 mM − 1 . These data suggest that MbNHase exhibits a higher affinity for aromatic nitrile substrates accessed by following the link in the citation at the bottom of the page.
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compared to aliphatic substrates, following the trend observed for most Co-type NHases. 4, 15 
Metal analysis and spectral characterization of MbNHase
A combination of UV-Vis spectroscopy and metal analysis was used to determine if MbNHase expressed in the absence of an activator protein contained its full complement of Co(III). After purification, MbNHase expressed in the presence of 0.25 mM CoCl2 exhibits the characteristic amber color of a Co-type NHase enzymes (Fig. 2B,  inset) .
2 ICP-MS data indicate that MbNHase expressed in the presence of 0.25 mM CoCl2 contained ~ 1.8 equivalents of cobalt per homodimer while MbNHase expressed in the absence of CoCl2 contained 1.6 cobalt ions per homodimer. The UV-Vis spectrum of MbNHase expressed in the presence and absence of cobalt shows the characteristic S → Fe(III) ligand-to-metal-charge-transfer (LMCT) band at ~ 320 nm (ε = 19,392 M − 1 cm − 1 ) (Fig. 2B) . 2 These data show that MbNHase contains its full complement of Co(III) and can thus be expressed in E. coli in the absence of a Co-type NHase activator protein or the E. coli molecular chaperones GroES/EL. Given the high iron content of LB media, these data also suggest that the MbNHase has high affinity for cobalt and can be classified as a Co-type NHase.
All Fe-and Co-type NHase enzymes reported to date require the co-expression of an activator protein for metal ion insertion and the post-translational oxidation of the two equatorial active site cysteine residues.
11, 25 The only exception is CtNHase. 12 For M. brevicollis, no ORF encoding for an NHase activator or accessory protein, which is usually found downstream of the prokaryotic NHase genes, has been reported. 13, 14 Based on the binding ability of MbNHase during purification to the Ni-NTA column material, even though no His-tag was engineered, it is clear that the histidine-rich region found in the insert between the β-and α-subunits of MbNHase is capable of tight, but reversible binding of divalent transition metal ions. It is tempting, then, to speculate that the histidine-rich insert plays a role similar to that of the activator protein in metal acquisition and/or insertion. Histidine rich regions are present in some proteins of the cobalamin (vitamin B12) biosynthetic pathway, e.g., the chelatase CbiX enzyme accessed by following the link in the citation at the bottom of the page.
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from Bacillus megaterium and CobW from Pseudomonas denitrificans. 26 Histidine rich regions are also found in metallochaperone and accessory proteins involved in metallocenter assembly of nickel hydrogenases and ureases, such as HypB from Bradyrhizobium japonicum and Rhizobium leguminosarum, SlyD from Escherichia coli and Helicobacter pylori, UreE from Klebsiella aerogenes, Hpn and Hpn-like proteins from Helicobacter pylori. 27 Based on the similarity of the histidine rich region with accessory proteins involved in the metallocenter assembly of cobalamin, hydrogenases, and ureases, it is possible that the histidine rich insert that links the β-and α-subunits of MbNHase, and those found in other eukaryotic NHases, play a role in cobalt binding and possible insertion of the cobalt ion into the active site.
Homology model of MbNHase
Since no three-dimensional X-ray crystal structure exists for MbNHase, a homology model was developed using the X-ray crystal structure of the prototypical prokaryotic Co-type NHase from Pseudonocardia thermophila JCM 3095 (PtNHase; PDB code: 1IRE) as a template (Fig. 3A) . Only the α-and β-subunits of MbNHase were modeled as no suitable template structure exists for the entire MbNHase peptide. The α-and β-subunit model of MbNHase suggests that it is, in general, structurally similar to other Co-type NHase enzymes ( Fig. 3A) . The α-subunit of MbNHase is embedded in the center of the β-subunit, while the N-terminus of the α-subunit forms a helix that is embedded among three helices from the β-subunit. The model reveals that within 4.0 Å of the Co(III) binding site, all of the amino acid residues are identical to those in PtNHase. The Co(III) ion of MbNHase is five coordinate and bound by C400, C403, and C405 as well as two backbone amide nitrogen's, where C403 and C405 are both modeled as oxidized cysteine-sulfinic and cysteine-sulfenic acids, respectively ( Fig. 3B) . The oxidation of the equatorial Cys residues is expected since MbNHase exhibits nitrile hydratase activity and oxidation of the equatorial Cys residues is required for catalytic activity. 6 Two amide nitrogen atoms and the oxidized sulfur atoms are roughly in the same plane as the metal ion. The sulfur atom from C400 forms a coordination bond roughly perpendicular to this plane, which results in a slightly distorted square-based pyramidal geometry. On the opposite side of C400, no sixth ligand such as water was modeled but is often observed for Co-type NHase enzymes. 2 The sulfinic and sulfenic acid ligands are within hydrogen bonding distance of two strictly conserved and catalytically important β-Arg56 and β-Arg167 residues found in Co-type NHase enzymes. These Arg residues are conserved in all bacterial NHases and play a role in the stabilization of the "claw-setting" structure through the hydrogen bonding. 
Conclusion
The construct presented here provides the first evidence of a functional subunit-fused eukaryotic NHase. We found that expression of MbNHase does not require an NHase activator protein or the E. coli chaperone proteins GroEL/ES. These data are contrary to the accepted view regarding the strict requirement of co-expressing NHases with activator proteins for fully active enzymes. Based on UV-Vis and ICP-MS data, MbNHase binds it full complement of Co(III) ions in its active site and the equatorial Cys residues are appropriately oxidized, which is a requirement for full enzymatic activity. Both metal ion insertion and Cys oxidation are functions previously ascribed to NHase activator accessed by following the link in the citation at the bottom of the page.
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proteins. The homology model suggests that the MbNHase polypeptide encoding for the α-and β-subunits is capable of folding like a prototypical prokaryotic Co-type NHase. The position of the predicted active site residues of MbNHase align with those of PtNHase including the highly conserved β-Arg residues in prokaryotic Co-type NHases that form hydrogen bonds to the active site oxidized Cys residues. 28 Both of these β-Arg residues are catalytically important for both Feand Co-type prokaryotic NHase enzymes. Since MbNHase is a new member of the NHase family that is expressed from a single gene without the requirement of an activator protein, it represents an alternative biocatalyst for industrial syntheses of important amide compounds. accessed by following the link in the citation at the bottom of the page. (Fig. SI-1) , a size-exclusion chromatography elution profile ( Fig. SI-2) , and an image of an SDS-PAGE for apo MbNHase (Fig. SI-3 
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